These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 22973399)
21. Novel insights into antidepressant mechanism of Kai Xin San formula: Inhibiting NLRP3 inflammasome activation by promoting autophagy. Yu S; Liu S; Wang N; Yu D; Qin M; Wu J; Guan Q Phytomedicine; 2021 Dec; 93():153792. PubMed ID: 34735906 [TBL] [Abstract][Full Text] [Related]
22. Neuroprotective mechanism of Wang N; Jia YM; Zhang B; Xue D; Reeju M; Li Y; Huang SM; Liu XW Neural Regen Res; 2017 Apr; 12(4):654-659. PubMed ID: 28553348 [No Abstract] [Full Text] [Related]
23. Kai-Xin-San, a traditional Chinese medicine formulation, exerts antidepressive and neuroprotective effects by promoting pCREB upstream pathways. Dong XZ; Wang DX; Yu BY; Liu P; Hu Y Exp Ther Med; 2016 Nov; 12(5):3308-3314. PubMed ID: 27882154 [TBL] [Abstract][Full Text] [Related]
24. KXS Balances the Tryptophan Metabolism in Mild to Moderate Depressed Patients and Chronic Restraint Stress Induced Depressive Rats. Wang Y; Li X; Jing R; Yang W; Wang Y; Wang C; Yao L; Cui X; Hu Y Neuropsychiatr Dis Treat; 2022; 18():2485-2496. PubMed ID: 36345420 [TBL] [Abstract][Full Text] [Related]
25. Kai-Xin-San, a Chinese Herbal Decoction, Accelerates the Degradation of Wang N; Jia Y; Zhang B; Li Y; Murtaza G; Huang S; Liu X Evid Based Complement Alternat Med; 2020; 2020():3862342. PubMed ID: 32148540 [TBL] [Abstract][Full Text] [Related]
26. Kai-Xin-San Protects Depression Mice Against CORT-Induced Neuronal Injury by Inhibiting Microglia Activation and Oxidative Stress. Bai G; Jing S; Cao H; Qiao Y; Chen G; Duan L; Yang Y; Li M; Li W; Chang X; Yang C; Wang Q Evid Based Complement Alternat Med; 2022; 2022():5845800. PubMed ID: 36310618 [TBL] [Abstract][Full Text] [Related]
27. Efficacy of Chinese herbal formula Kai-Xin-San on rodent models of depression: A systematic review and meta-analysis. Wang YT; Wang XL; Lei L; Guo ZY; Hu D; Wang ZZ; Zhang Y J Ethnopharmacol; 2024 Mar; 321():117492. PubMed ID: 38012974 [TBL] [Abstract][Full Text] [Related]
28. Behavioral and Biochemical Effects of KXS on Postmyocardial Infarction Depression. Hu Y; Liu X; Zhang T; Chen C; Dong X; Can Y; Liu P Front Pharmacol; 2020; 11():561817. PubMed ID: 32973539 [TBL] [Abstract][Full Text] [Related]
29. Antidepressant effects of Kai-Xin-San in fluoxetine-resistant depression rats. Dong XZ; Wang DX; Lu YP; Yuan S; Liu P; Hu Y Braz J Med Biol Res; 2017 Aug; 50(10):e6161. PubMed ID: 28832762 [TBL] [Abstract][Full Text] [Related]
30. Exploring the anti-ferroptosis mechanism of Kai-Xin-San against Alzheimer's disease through integrating network pharmacology, bioinformatics, and experimental validation strategy in vivo and in vitro. Yan C; Yang S; Shao S; Zu R; Lu H; Chen Y; Zhou Y; Ying X; Xiang S; Zhang P; Li Z; Yuan Y; Zhang Z; Wang P; Xie Z; Wang W; Ma H; Sun Y J Ethnopharmacol; 2024 May; 326():117915. PubMed ID: 38360383 [TBL] [Abstract][Full Text] [Related]
31. Effects of a Chinese traditional formula Kai Xin San (KXS) on chronic fatigue syndrome mice induced by forced wheel running. Cao Y; Hu Y; Liu P; Zhao HX; Zhou XJ; Wei YM J Ethnopharmacol; 2012 Jan; 139(1):19-25. PubMed ID: 21884774 [TBL] [Abstract][Full Text] [Related]
32. [Effect of Kaixin San on learning and memory in chronic stress depression model rats]. Liu M; Yan J; Zhou X; Hu Y; Liu P Zhongguo Zhong Yao Za Zhi; 2012 Aug; 37(16):2439-43. PubMed ID: 23234145 [TBL] [Abstract][Full Text] [Related]
33. Kai-Xin-San Inhibits Tau Pathology and Neuronal Apoptosis in Aged SAMP8 Mice. Jiao YN; Zhang JS; Qiao WJ; Tian SY; Wang YB; Wang CY; Zhang YH; Zhang Q; Li W; Min DY; Wang ZY Mol Neurobiol; 2022 May; 59(5):3294-3309. PubMed ID: 35303280 [TBL] [Abstract][Full Text] [Related]
34. Systems Pharmacology Approach to Investigate the Mechanism of Kai-Xin-San in Alzheimer's Disease. Luo Y; Li D; Liao Y; Cai C; Wu Q; Ke H; Liu X; Li H; Hong H; Xu Y; Wang Q; Fang J; Fang S Front Pharmacol; 2020; 11():381. PubMed ID: 32317964 [TBL] [Abstract][Full Text] [Related]
35. Metabolomics approach to explore the effects of Kai-Xin-San on Alzheimer's disease using UPLC/ESI-Q-TOF mass spectrometry. Chu H; Zhang A; Han Y; Lu S; Kong L; Han J; Liu Z; Sun H; Wang X J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Mar; 1015-1016():50-61. PubMed ID: 26896572 [TBL] [Abstract][Full Text] [Related]
36. The Traditional Formula Kai-Xin-San Alleviates Polyglutamine-Mediated Neurotoxicity by Modulating Proteostasis Network in Xiao L; Li H; Tian J; Jin N; Zhang J; Yang F; Zhou L; Wang Q; Huang Z Rejuvenation Res; 2020 Jun; 23(3):207-216. PubMed ID: 31985332 [TBL] [Abstract][Full Text] [Related]
37. A Comparative Study of Serum Pharmacochemistry of Kai-Xin-San in Normal and AD Rats Using UPLC-LTQ-Orbitrap-MS. Yang L; Liang J; Zheng Q; Zhou L; Xiong Y; Wang H; Yuan J Pharmaceuticals (Basel); 2022 Dec; 16(1):. PubMed ID: 36678527 [TBL] [Abstract][Full Text] [Related]
38. Kai-Xin-San protects against mitochondrial dysfunction in Alzheimer's disease through SIRT3/NLRP3 pathway. Su S; Chen G; Gao M; Zhong G; Zhang Z; Wei D; Luo X; Wang Q Chin Med; 2023 Mar; 18(1):26. PubMed ID: 36918872 [TBL] [Abstract][Full Text] [Related]
39. Evaluation of the chronic oral toxicity of the classical ancient prescription Kai-Xin-San. Zhang H; Yang Y; Zhao C; Xia B; Su P; Gong P; Gao S; Ma M; Deng B; Cao C; Liu T J Ethnopharmacol; 2025 Jan; 337(Pt 3):118931. PubMed ID: 39396716 [TBL] [Abstract][Full Text] [Related]
40. Acute and subchronic oral toxicity assessment of the herbal formula Kai-Xin-San. Mu LH; Huang ZX; Liu P; Hu Y; Gao Y J Ethnopharmacol; 2011 Nov; 138(2):351-7. PubMed ID: 21884776 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]